Cargando…

Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy

The past decades have witnessed great progress in cancer immunotherapy, which has profoundly revolutionized oncology, whereas low patient response rates and potential immune‐related adverse events remain major clinical challenges. With the advantages of controlled delivery and modular flexibility, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Shaojun, Xiao, Fengfeng, Chen, Meiwan, Gao, Huile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728817/ https://www.ncbi.nlm.nih.gov/pubmed/34796689 http://dx.doi.org/10.1002/advs.202103836

Ejemplares similares

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022)

Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy
por: Li, Jinyang, et al.
Publicado: (2023)

Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
por: Zhu, Yuefei, et al.
Publicado: (2020)

Light-responsive nanomedicine for cancer immunotherapy
por: Kang, Weirong, et al.
Publicado: (2023)

Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy
por: Mpekris, Fotios, et al.
Publicado: (2022)

Neurotoxicity of nanomaterials and nanomedicine
por: Jiang, Xinguo, et al.
Publicado: (2016)

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
por: Zhang, Bo, et al.
Publicado: (2017)

Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
por: Chen, Qinjun, et al.
Publicado: (2021)

Recent Advances of Tumor Microenvironment-Responsive Nanomedicines-Energized Combined Phototherapy of Cancers
por: Liu, Kehan, et al.
Publicado: (2023)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
por: Dong, Xiao, et al.
Publicado: (2023)

Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy
por: Su, Yuanzhen, et al.
Publicado: (2023)

Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine
por: Wang, Xuan, et al.
Publicado: (2022)

Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy
por: Wei, Xiao, et al.
Publicado: (2022)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
por: Ren, Mengdi, et al.
Publicado: (2022)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy
por: Mao, Qianqian, et al.
Publicado: (2022)

Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
por: Li, Wei, et al.
Publicado: (2020)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Nanomedicine for Combination Urologic Cancer Immunotherapy
por: Tian, Yun, et al.
Publicado: (2023)

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
por: Devaud, Christel, et al.
Publicado: (2013)

Supramolecular nanomedicines based on host–guest interactions of cyclodextrins
por: Tong, Fan, et al.
Publicado: (2023)

Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
por: Yang, Yunrong, et al.
Publicado: (2022)

Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy
por: Zhao, Yijun, et al.
Publicado: (2021)

Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2018)

Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)

Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Emerging nanomedicines for effective breast cancer immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2020)

Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
por: Omidi, Yadollah, et al.
Publicado: (2014)

Tumor microenvironment and immunotherapy of oral cancer
por: Liu, Chang, et al.
Publicado: (2022)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
por: Liu, Qiaoqiao, et al.
Publicado: (2022)

Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
por: Sharma, Prashant, et al.
Publicado: (2023)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
por: Li, Jin, et al.
Publicado: (2020)

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2023)

Nanomedicine in Lung Cancer Immunotherapy
por: Doroudian, Mohammad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ttjqcmuvk05tbtvem45es3pasp